Search for: "Sees v. Sees"
Results 481 - 500
of 121,691
Sorted by Relevance
|
Sort by Date
26 Jan 2017, 4:00 am
(See Cal. [read post]
8 Aug 2010, 9:48 pm
Becton, Dickinson & Co. warranted en banc consideration, and asked the parties to brief ten questions concerning the issue of inequitable conduct (see "Federal Circuit Grants En Banc Review in Therasense v. [read post]
24 Nov 2020, 9:59 pm
Cir. 2019)" and "NeuroGrafix v. [read post]
3 Aug 2020, 9:59 pm
Noonan -- Earlier this year, the Federal Circuit (somewhat surprisingly) found claims of two Sequenom patents directed to methods for detecting fetal DNA in maternal blood to satisfy the subject matter eligibility requirements of Section 101 (see "Illumina, Inc. v. [read post]
8 May 2023, 2:02 pm
Contract Interpretation California Law (…) See Cundall v. [read post]
12 Oct 2020, 9:59 pm
Noonan -- The Federal Trade Commission carried out an (in)famous crusade against reverse payment (more provocatively, "pay for delay") settlements in ANDA litigation for almost a decade before eventually having the Supreme Court see things their way (to some extent) in FTC v Actavis. [read post]
19 Apr 2020, 9:41 pm
Prometheus Labs., Inc. and Alice Corp. v. [read post]
19 Feb 2023, 9:16 pm
§ 112(a) (see "Amgen Files Its Principal Brief in Amgen v. [read post]
12 Sep 2021, 9:59 pm
Noonan -- Imposition of liability under the equitable doctrine of inequitable conduct (as it has been variously defined) can result in a patent being held unenforceable; for this reason, former Chief Judge Rader called it the "atomic bomb of patent law" (see Aventis Pharma S.A. v. [read post]
5 May 2020, 9:37 pm
Noonan -- The Federal Circuit continued its explication of the standing issue for unsuccessful petitioners in inter partes review (see "Argentum Pharmaceuticals LLC v. [read post]
14 Aug 2022, 8:47 pm
Noonan -- A little more than three years ago, the Federal Circuit rejected the University of Minnesota's contention that LSI was barred from bringing (and the Patent Trial and Appeal Board barred from hearing) an inter partes review of certain University-owned patents under the sovereign immunity doctrine; see "Regents of the University of Minnesota v. [read post]
24 Sep 2008, 10:30 am
Boston Red Sox Baseball Club Limited Partnership v. [read post]
10 Jan 2011, 7:35 am
In 2010, U.S. companies obtained 50.3% of granted patents, compared with 49% in 2009.High-tech patents also dominated areas with the heaviest new patenting activity:Multiplex Communications (US class 370) -- 3.3% of totalSolid-State Devices and Transistors (US class 257) -- 3.1%Semiconductors (US class 438) -- 2.7%Drug Compositions (US class 514) -- 2.1% Data Processing and File Management (US class 707) -- 2%Computers and Processing Systems (US class 709) -- 2%… [read post]
1 Jan 2023, 9:16 am
Defending Our Progress Since EFF has started working to improve the patent system, we’ve seen a few big steps forward, like the introduction of inter partes review (IPR), and the 2014 Alice v. [read post]
25 Jul 2012, 9:34 pm
In the April 2011 New Jersey case VanBrunt v. [read post]
30 Oct 2023, 11:00 pm
Subchapter V and Small Business Case Filing Chart See this chart for the requirements for filing a Subchapter V and a small business case. [read post]
4 Jun 2007, 8:15 am
The Oregon Supreme Court decided on Friday, 6/1/07, in State v. [read post]
28 Aug 2017, 3:30 pm
CONSTITUTION V. [read post]
3 Jun 2009, 9:56 pm
§ 120 (see Patent Docs report). [read post]
3 Nov 2010, 9:59 pm
Noonan -- The American Intellectual Property Law Association (AIPLA) filed an amicus brief in the Myriad case (Association of Molecular Pathology v. [read post]
